Item 5. Other Information
Item
5. Other Information
None.
12
Item
6. Exhibits
EXHIBIT
INDEX
Exhibit
No.
Description
3.1
Amended
and Restated Certificate of Incorporation, as amended through September 30, 2015 (incorporated by reference to Exhibit 3.1 to Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2015)
3.2
Amended
and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Current Report on Form 8-K filed with the Securities and Exchange
Commission on June 29, 2021)
3.3
Certificate
of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc. (incorporated by reference to Exhibit 3.1 to
the Current Report on Form 8-K filed on May 25, 2016)
3.4
Certificate
of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc. (incorporated by reference to Exhibit 3.1 to
the Current Report on Form 8-K filed on September 29, 2016)
3.5
Certificate
of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Current Report on Form 8-K filed on March 15, 2017)
3.6
Certificate
of Amendment to Certificate of Designation of Preferences, Rights and Limitation of Series C Convertible Preferred Stock (incorporated
by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on November 29, 2017)
3.7
Certificate
of Amendment to Certificate of Designation of Preferences, Rights and Limitation of Series B Convertible Preferred Stock (incorporated
by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on December 12, 2017)
3.8
Certificate
of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc. (incorporated by reference to Exhibit 3.1 to
the Current Report on Form 8-K filed on February 7, 2018)
3.9
Certificate
of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc. (incorporated by reference to Exhibit 3.1 to
the Current Report on Form 8-K filed on March 28, 2019)
3.10
Certificate
of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc., dated April 14, 2021 (incorporated by reference
to Exhibit 3.17 to the Quarterly Report on Form 10-Q filed on May 10, 2021)
31.1*
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification
of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification
of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101*
The
following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in inline
XBRL (eXtensible Business Reporting Language), (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements
of Operations, (iii) Condensed Consolidated Statements of Cash Flows, and (v) the Notes to the Condensed Consolidated Financial Statements
104*
Cover
Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
*
Filed herewith.
+
Management contract or compensatory plan or arrangement.
13
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
INSPIREMD,
INC.
Date:
November 7, 2022
By:
/s/
Marvin Slosman
Name:
Marvin
Slosman,
Title:
President
and Chief Executive Officer
(Principal
Executive Officer)
Date:
November 7, 2022
By:
/s/
Craig Shore
Name:
Craig
Shore
Title:
Chief
Financial Officer, Secretary and Treasurer
(Principal
Financial and Accounting Officer)
14
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.